Product
Help
Pricing
About
Jobs
Log in
Get started
Concept
Add to collection
Taxane
OpenAlex ID:
C2777511904
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
2006
·
Charles E. Geyer
, John Forster
, et al.
·
New England Journal of Medicine
·
3,713
PDF
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010
·
Johann Sebastian de Bono
, Stephane Oudard
, et al.
·
The Lancet
·
3,586
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012
·
Gunter von Minckwitz
, Michael Untch
, et al.
·
Journal of Clinical Oncology
·
2,926
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005
·
William J. Gradishar
, Sergei Tjulandin
, et al.
·
Journal of Clinical Oncology
·
2,322
Paclitaxel (Taxol)
1995
·
Eric K. Rowinsky
, Ross C. Donehower
·
New England Journal of Medicine
·
2,210
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
2020
·
Javier Cortes
, David W Cescon
, et al.
·
The Lancet
·
2,073
Taxol and Taxane Production by Taxomyces andreanae , an Endophytic Fungus of Pacific Yew
1993
·
Andrea Stierle
, Gary Strobel
, et al.
·
Science
·
2,023
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
2009
·
Andreas du Bois
, Alexander Reuss
, et al.
·
Cancer
·
1,930
PDF
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
2009
·
Carsten Denkert
, Sibylle Loibl
, et al.
·
Journal of Clinical Oncology
·
1,909
Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group
2005
·
Michel Marty
, Francesco Cognetti
, et al.
·
Journal of Clinical Oncology
·
1,715
PDF
Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer
2005
·
Kathy D. Miller
, Linnea I. Chap
, et al.
·
Journal of Clinical Oncology
·
1,365
PDF
[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
2018
·
Michael S Hofman
, John Violet
, et al.
·
The Lancet Oncology
·
1,267
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
2011
·
Javier Cortes
, Joyce O'Shaughnessy
, et al.
·
The Lancet
·
1,198
Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment
2009
·
Carla M.M. Prado
, Vickie E. Baracos
, et al.
·
Clinical Cancer Research
·
1,185
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
2021
·
Larissa A. Korde
, Mark R. Somerfield
, et al.
·
Journal of Clinical Oncology
·
1,184
Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results
2002
·
Joyce O’Shaughnessy
, David Miles
, et al.
·
Journal of Clinical Oncology
·
1,124
Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
2014
·
Gunter von Minckwitz
, Andreas Schneeweiss
, et al.
·
The Lancet Oncology
·
1,121
Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer
2008
·
Antonino Musolino
, Nadia Naldi
, et al.
·
Journal of Clinical Oncology
·
1,085
PDF
Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers
2019
·
Sherene Loi
, Damien Drubay
, et al.
·
Journal of Clinical Oncology
·
994
Nanoparticles for drug delivery in cancer treatment
2008
·
Barbara Haley
, Eugene Frenkel
·
Urologic Oncology Seminars and Original Investigations
·
963
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
2009
·
Sao Jiralerspong
, Shana L. Palla
, et al.
·
Journal of Clinical Oncology
·
934
Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies
2004
·
Tae-You Kim
, Dong-Wan Kim
, et al.
·
Clinical Cancer Research
·
893
A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses
2008
·
David Cameron
, Michelle Casey
, et al.
·
Breast Cancer Research and Treatment
·
858
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
2021
·
D. Miles
, J. Gligorov
, et al.
·
Annals of Oncology
·
831
PDF
Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer
1999
·
Joanne L. Blum
, Stephen E. Jones
, et al.
·
Journal of Clinical Oncology
·
797
Show more works
View as search
Works count:
14,150
Citation count:
337,600
Year
Topic
Type